Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 140 Esophageal Neoplasms 71 Pancreatic Neoplasms 42 Esophageal Squamous Cell Carcinoma 26 Carcinoma, Non-Small-Cell Lung 24 Adenocarcinoma Of Esophagus 23 Breast Neoplasms 18 Neoplasms 15 Neoplasm Metastasis 15 Colorectal Neoplasms 15 Prostatic Neoplasms 11 Ovarian Neoplasms 9 Melanoma 9 Squamous Cell Carcinoma of Head and Neck 8 Lung Neoplasms 8 Adenocarcinoma 8 Sarcoma 7 Colonic Neoplasms 7 Biliary Tract Neoplasms 7 Small Cell Lung Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Carcinoma, Renal Cell 6 Urinary Bladder Neoplasms 5 Gastrointestinal Neoplasms 5 Gallbladder Neoplasms 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 4 Salivary Gland Neoplasms 4 Rectal Neoplasms 4 Head and Neck Neoplasms 4

Interventions

Fluorouracil 9 Radiotherapy 7 Cisplatin 7 Radiotherapy, Intensity-Modulated 4 Mitomycin 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiation 3 Nivolumab 3 Capecitabine 3 dehydroftorafur 2 Taxes 2 Paclitaxel 2 Cetuximab 2 Carboplatin 2 Biopsy 2 toripalimab 1 rocakinogene sifuplasmid 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 X-Rays 1 Watchful Waiting 1 Vaccines 1 VGX-3100 1 Sigmoidoscopy 1 Radiosurgery 1 Proctoscopy 1 Platinum 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Canal Carcinoma × Docetaxel × Gastrointestinal × Clear all

NCT02402842 2022-05-16

Epitopes-HPV02

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed

Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡